2025 promises further advancements that will continue to shape ADHD diagnosis, treatment, and support for practitioners as well…
Blog
Optimize ADHD treatment approach through a strengths-based model of care: Key insights from our webinar
A strengths-based approach to ADHD care focuses on the unique capabilities of each patient – allowing you to…
Enhancing the use of data-driven ADHD care in your service
Clinics worldwide are facing growing demand for ADHD services, exposing operational bottlenecks in many clinics including long wait…
Vorteile und Herausforderungen von ADHS-Ferntests in Deutschland
Bei der Diagnose von ADHS in Deutschland muss man sich in einem umfassenden und manchmal komplexen medizinischen System…
Exploring ADHD and women’s health and hormones: Key insights from our webinar
In recent years, there has been growing awareness of how ADHD uniquely affects women across their lifespan, particularly…
QbTest is the first digital technology recommended by NICE to assess ADHD
QbTest has officially been evaluated and recommended within the National Institute of Health and Care Excellence (NICE) Diagnostics…
The guide to objective ADHD testing for clinicians
Behavioral assessments, rating scales, and patient interviews often dominate assessment pathways yet carry the risk of subjectivity. More…
What is ADHD? A guide to ADHD diagnosis, co-morbidity & treatment
Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental condition, affecting 5% of the global population. There…
Absent or hidden? Hyperactivity in females with ADHD (2024)
Journal of Attention Disorders (Wettstein, R., Ovando, V. N. & Dumont, G.) View
Utilizing remote objective ADHD testing to monitor symptom improvement following medication treatment (2024)
International Journal of Psychiatry Research (Sanyal, R. Y., Nolen R., Gustafsson, U. & Hansen, M.) View